Face Max Stack
Risk: ModerateSkin quality, collagen density, jawline definition, and hair optimization — for maximising facial aesthetics.
Overview
The Face Max Stack targets the key levers of facial aesthetics: skin quality and collagen density (BPC-157, GLOW's GHK-Cu component), GH-driven elasticity and recovery (CJC-1295/Ipamorelin), hair retention (Finasteride), and surface skin renewal (Retinol). These compounds work on different pathways and can be run together with minimal interactions.
Why this stack works
BPC-157: Stimulates collagen synthesis and fibroblast activity, improving skin elasticity and facial skin quality. Also reduces systemic inflammation that contributes to skin aging.
GLOW: Three-peptide blend (BPC-157 + GHK-Cu + TB-500). The GHK-Cu component is one of the most studied skin-rejuvenating peptides — stimulates collagen, elastin, and glycosaminoglycan synthesis. TB-500 adds systemic recovery. If you're already running BPC-157 standalone, GLOW lets you swap to a single injection that adds GHK-Cu and TB-500 without doubling up.
CJC-1295 / Ipamorelin: Pulsatile GH release indirectly improves skin elasticity and dermal thickness via IGF-1, and supports the recovery substrate the other peptides build on.
Finasteride: Inhibits 5-alpha reductase, reducing DHT conversion. Prevents follicle miniaturisation and is the most evidence-backed hair retention compound available.
Retinol: The gold standard topical for skin renewal. Increases cell turnover, stimulates collagen production, and reduces fine lines. Start at 0.25% and build tolerance before moving to higher concentrations.
Protocol timeline
1 phase · 16 weeks total
Timeline shows the 16-week cycle. Bars overlap when phases run concurrently. Click a bar to jump to its detail card.
Cycle starts
2025
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2027
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
| Compound | Dose | Frequency | Method |
|---|---|---|---|
| BPC-157 | 250–500mcg | Daily | SubQ or oral |
| GLOW (BPC-157 + GHK-Cu + TB-500) | per-component (see GLOW page) | BPC/GHK daily, TB-500 weekly | SubQ |
| CJC-1295 / Ipamorelin | 100–200mcg each | 2× daily SubQ (AM + pre-sleep) | SubQ |
| Finasteride | 1mg | Daily | Oral |
| Retinol (Vitamin A) | 0.25–1% cream | Nightly | Topical |
Items needed for this phase
- Finasteride 1mg— Rx required (e.g. Hims, Keeps)
- Retinol 0.25–1% cream— OTC — start low, build tolerance
Ancillaries:
- BPC-157 and GLOW overlap on BPC-157 — pick one or the other if you want to keep dosing simple. Listed together to show both options
- Finasteride: basic liver function monitoring recommended long-term
- Ensure adequate dietary fat intake (needed for fat-soluble vitamin/collagen synthesis)
- Sunscreen — retinol increases photosensitivity
Where to buy
- Finasteride 1mgFace Max— Rx required (e.g. Hims, Keeps)
- Retinol 0.25–1% creamFace Max— OTC — start low, build tolerance
Conclusion
The Face Max Stack is one of the lower-risk stacks in the library — most of these compounds are available OTC, via prescription, or as research peptides. The combination addresses skin, hair, and collagen systematically. Results take time: expect meaningful improvement at 12–16 weeks.